cobas^® HSV 1 and 2 Test

Molecular testing by polymerase chain reaction (PCR) technology is regarded as the most sensitive method of direct detection for Herpes Simplex Virus (HSV) 1 and 2.¹

The cobas^® HSV 1 and 2 test for use on the cobas^® 4800 System utilizes a dual-target approach to ensure accurate identification of HSV-1 and HSV-2 from genital lesions.

Compared to a CE- and FDA-cleared nucleic acid amplification test (NAAT), cobas® HSV 1 and 2 delivers high sensitivity and specificity in the direct detection of HSV-1 and HSV-2 DNA in clinical specimens.*

The cobas^® HSV 1 and 2 uniquely delivers dual-target detection that amplifies two separate regions on each of the HSV-1 and HSV-2 genomes. Since drug-resistant mutations can occur at certain sites, this approach provides confidence in the detection of existing and emerging strains of HSV.

The cobas^® HSV 1 and 2 saves time with first-of-its-kind primary vial loading. Using the MSwab^™ system, specimens collected on a FLOQSwab^™ are transferred directly into the primary vial for testing. The MSwab system is optimized for molecular and culture applications.

Perform cobas^® HSV 1 and 2 on as few as 6 or as many as 94 specimens, using the fastest, most advanced real-time PCR amplification and detection available today. Labs can run 4 to 5 small runs or 2 high-volume runs for up to 194 results/day.

1. De-cap primary vial and load
2. Fully automated sample extraction and result generation
3. 4 to 5 small runs or 2 high-volume runs for up to 192 results per day

The cobas^® HSV 1 and 2 on the cobas^® 4800 System requires 77% less hands-on time than a competitive CE- and FDA-cleared nucleic acid amplification test. Just load your primary sample vials and you’re ready to go.

The parallel sample processing capabilities of the cobas^® 4800 System allows cobas^® HSV 1 and 2 samples to be run with different tests and sample types in a single run.

Run mixed batch assays of:

• Anogenital lesions (cobas^® HSV 1 and 2 Test)
• Nasal (cobas^® MRSA/SA Test)
• Stool (cobas^® Cdiff Test)

Streamline your sexually transmitted infection portfolio with the expanded test menu of the cobas^® 4800 System—test for Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) on the same system with the same Roche quality results.